Northwest Biotherapeutics Inc
NWBO- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001072379
No open-market purchases or sales by Northwest Biotherapeutics Inc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $413.6K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Northwest Biotherapeutics Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Northwest Biotherapeutics Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Boynton Alton L | CHIEF SCIENTIFIC OFFICER | – | Sep 3, 2024 | 0 |
| Bosch Marnix L | CHIEF TECHNICAL OFFICER | 119,355 | Aug 13, 2024 | 0 |
| Malik Navid | Director | 0 | Jul 30, 2024 | 0 |
| Jasinowski Jerry J | Director | 28,235 | Dec 5, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2024 (view filing)7:49 PM ET | Jul 26 | 4 days | Malik NavidDirector | SSale | −657.9K | $0.38 | −$250.0K | –23.3M after | Derivative |
| Dec 1, 2023 (view filing) | Nov 16-17 | 15 daysLate | Malik NavidDirector | SSale | +570.0K | $0.8244 | +$469.9K | New position0 after | 3 lots |